Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Sandra Luna-Fineman to Precursor Cell Lymphoblastic Leukemia-Lymphoma

This is a "connection" page, showing publications Sandra Luna-Fineman has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.

 
Connection Strength
 
 
 
0.611
 
  1. Pribnow AK, Ortiz R, Báez LF, Mendieta L, Luna-Fineman S. Effects of malnutrition on treatment-related morbidity and survival of children with cancer in Nicaragua. Pediatr Blood Cancer. 2017 Nov; 64(11).
    View in: PubMed
    Score: 0.422
  2. de Smith AJ, Walsh KM, Morimoto LM, Francis SS, Hansen HM, Jeon S, Gonseth S, Chen M, Sun H, Luna-Fineman S, Antillón F, Girón V, Kang AY, Smirnov I, Shao X, Whitehead TP, Barcellos LF, Jolly KW, Healy J, Laverdière C, Sinnett D, Taub JW, Birch JM, Thompson PD, Pombo-de-Oliveira MS, Spector LG, DeWan AT, Mueller BA, Chiang C, Metayer C, Ma X, Wiemels JL. Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome. Leukemia. 2019 11; 33(11):2746-2751.
    View in: PubMed
    Score: 0.123
  3. Luna-Fineman S, Healy MV, Parker BR. Corticosteroid pretreatment for potential contrast reactions in children with lymphoreticular cancer: a word of caution. AJR Am J Roentgenol. 1990 Aug; 155(2):357-8.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)